In our study, 478 (82.6%) of 579 prostate cancer patients were diagnosed at age > 60 (p < 0.001, Table 1), while more of the patients involved in our study had a PSA level at diagnosis of ≤ 10 ng/mL (53.4%, Table 1). The gene discussed is KLK3; the disease is prostate cancer.